Perceptive Advisors’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-60,000
Closed -$3.06M 126
2020
Q1
$3.06M Hold
60,000
0.08% 86
2019
Q4
$4.91M Buy
+60,000
New +$4.23M 0.1% 79
2019
Q2
Sell
-7,232
Closed -$1.33M 105
2019
Q1
$1.33M Hold
7,232
0.04% 81
2018
Q4
$1.27M Sell
7,232
-2,386
-25% -$520K 0.05% 79
2018
Q3
$3.08M Buy
9,618
+7,232
+303% +$2.57M 0.08% 79
2018
Q2
$954K Sell
2,386
-37,540
-94% -$16.4M 0.03% 95
2018
Q1
$14.2M Buy
39,926
+37,540
+1,573% +$13.9M 0.4% 54
2017
Q4
$946K Sell
2,386
-2,290
-49% -$947K 0.03% 101
2017
Q3
$1.99M Sell
4,676
-12,239
-72% -$3.29M 0.08% 93
2017
Q2
$2.71M Sell
16,915
-8,000
-32% -$1.09M 0.14% 77
2017
Q1
$3.11M Sell
24,915
-8,772
-26% -$1.13M 0.18% 73
2016
Q4
$4.08M Sell
33,687
-19,755
-37% -$3.09M 0.29% 62
2016
Q3
$8.02M Sell
53,442
-17,073
-24% -$1.67M 0.52% 48
2016
Q2
$4.16M Hold
70,515
0.29% 67
2016
Q1
$4.51M Hold
70,515
0.4% 59
2015
Q4
$5.92M Hold
70,515
0.44% 49
2015
Q3
$7.14M Buy
70,515
+51,715
+275% +$6.86M 0.57% 44
2015
Q2
$2.38M Sell
18,800
-31,200
-62% -$4.69M 0.14% 92
2015
Q1
$3.92M Hold
50,000
0.31% 60
2014
Q4
$4.38M Buy
+50,000
New +$4.48M 0.37% 58

Other funds holding ABEO

Perceptive Advisors's ABEO Position: Q2 2020 in Review

Perceptive Advisors sold out of Abeona Therapeutics (ABEO) in Q2 2020, closing a stake of 60,000 shares — an estimated $3.06M sold.

Perceptive Advisors first reported a position in ABEO in Q4 2014 and held it in 20 quarters. The position peaked at $14.2M in Q1 2018. 83 funds tracked by Wall St. Rank hold ABEO as of Q2 2020.

  • Perceptive Advisors reported no remaining Abeona Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Perceptive Advisors sold 60,000 Abeona Therapeutics shares in Q2 2020, an estimated $3.06M.
  • Perceptive Advisors first reported a position in Abeona Therapeutics in Q4 2014 and held it in 20 quarters.
  • Perceptive Advisors's Abeona Therapeutics position peaked at $14.2M in Q1 2018.
  • 83 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2020.

Based on Perceptive Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.